These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31861681)

  • 1. Overexpression of Mitochondrial IF1 Prevents Metastatic Disease of Colorectal Cancer by Enhancing Anoikis and Tumor Infiltration of NK Cells.
    González-Llorente L; Santacatterina F; García-Aguilar A; Nuevo-Tapioles C; González-García S; Tirpakova Z; Toribio ML; Cuezva JM
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the ATPase Inhibitory Factor 1 Favors a Non-metastatic Phenotype in Breast Cancer.
    García-Ledo L; Nuevo-Tapioles C; Cuevas-Martín C; Martínez-Reyes I; Soldevilla B; González-Llorente L; Cuezva JM
    Front Oncol; 2017; 7():69. PubMed ID: 28443245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ATPase Inhibitory Factor 1 (IF1) Contributes to the Warburg Effect and Is Regulated by Its Phosphorylation in S39 by a Protein Kinase A-like Activity.
    Cuezva JM; Domínguez-Zorita S
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers.
    Sánchez-Aragó M; Formentini L; Martínez-Reyes I; García-Bermudez J; Santacatterina F; Sánchez-Cenizo L; Willers IM; Aldea M; Nájera L; Juarránz A; López EC; Clofent J; Navarro C; Espinosa E; Cuezva JM
    Oncogenesis; 2013 Apr; 2(4):e46. PubMed ID: 23608753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of the Inhibition of the Mitochondrial ATP Synthase by IF1
    García-Aguilar A; Cuezva JM
    Front Physiol; 2018; 9():1322. PubMed ID: 30283362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Mitochondrial H
    Esparza-Moltó PB; Cuezva JM
    Front Oncol; 2018; 8():53. PubMed ID: 29564224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
    Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
    Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mitochondrial ATP Synthase/IF1 Axis in Cancer Progression: Targets for Therapeutic Intervention.
    Domínguez-Zorita S; Cuezva JM
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the H
    Esparza-Moltó PB; Nuevo-Tapioles C; Cuezva JM
    Cell Mol Life Sci; 2017 Jun; 74(12):2151-2166. PubMed ID: 28168445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival.
    García-Bermúdez J; Cuezva JM
    Biochim Biophys Acta; 2016 Aug; 1857(8):1167-1182. PubMed ID: 26876430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the ATPase inhibitor factor 1 (IF
    Sgarbi G; Barbato S; Costanzini A; Solaini G; Baracca A
    Biochim Biophys Acta Bioenerg; 2018 Feb; 1859(2):99-109. PubMed ID: 29097244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial H
    Formentini L; Ryan AJ; Gálvez-Santisteban M; Carter L; Taub P; Lapek JD; Gonzalez DJ; Villarreal F; Ciaraldi TP; Cuezva JM; Henry RR
    Diabetologia; 2017 Oct; 60(10):2052-2065. PubMed ID: 28770317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATPase inhibitory factor 1 inhibition improves the antitumor of YC-1 against hepatocellular carcinoma.
    Ding X; Kong J; Xu W; Dong S; Du Y; Yao C; Gao J; Ke S; Wang S; Sun W
    Oncol Lett; 2018 Oct; 16(4):5230-5236. PubMed ID: 30250592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATPase inhibitory factor 1 is a potential prognostic marker for the migration and invasion of glioma.
    Wu J; Shan Q; Li P; Wu Y; Xie J; Wang X
    Oncol Lett; 2015 Oct; 10(4):2075-2080. PubMed ID: 26622799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATPase inhibitory factor 1 expression is an independent prognostic factor in non-small cell lung cancer.
    Gao YX; Chen L; Hu XG; Wu HB; Cui YH; Zhang X; Wang Y; Liu XD; Bian XW
    Am J Cancer Res; 2016; 6(5):1141-8. PubMed ID: 27294006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of ATPase Inhibitory Factor 1 Inhibits Cell Growth via Cell Cycle Arrest in Bladder Cancer.
    Wei S; Fukuhara H; Kawada C; Kurabayashi A; Furihata M; Ogura S; Inoue K; Shuin T
    Pathobiology; 2015; 82(5):224-32. PubMed ID: 26381881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMPK/GSK3β/β-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming.
    Zhang P; Song Y; Sun Y; Li X; Chen L; Yang L; Xing Y
    FASEB J; 2018 Jul; 32(7):3924-3935. PubMed ID: 29505302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F
    Tanton H; Voronina S; Evans A; Armstrong J; Sutton R; Criddle DN; Haynes L; Schmid MC; Campbell F; Costello E; Tepikin AV
    Front Physiol; 2018; 9():833. PubMed ID: 30050450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATPase Inhibitory Factor 1 Promotes Hepatocellular Carcinoma Progression After Insufficient Radiofrequency Ablation, and Attenuates Cell Sensitivity to Sorafenib Therapy.
    Kong J; Yao C; Ding X; Dong S; Wu S; Sun W; Zheng L
    Front Oncol; 2020; 10():1080. PubMed ID: 32670888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation of
    Romero-Carramiñana I; Dominguez-Zorita S; Esparza-Moltó PB; Cuezva JM
    iScience; 2024 Jun; 27(6):109863. PubMed ID: 38799559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.